SCO­TUS rais­es ques­tions over le­gal stand­ing in abor­tion pill case

Last year
Pharma
FDA+

Astel­las wins ap­proval in Japan for Claudin18.2 ther­a­py af­ter US re­jec­tion

Last year
Pharma
FDA+

Ever­sana to work with pa­tient so­cial net­work to help phar­ma speed time to di­ag­no­sis and treat­ment

Last year
Pharma
Marketing

Pfiz­er stops one of two Phase 3 tri­als for sick­le cell drug, still plans to seek ap­proval in 2026

Last year
R&D
Pharma

Hunt­ing for ‘cer­tain­ty and sta­bil­i­ty,’ WuXi Bio spot­lights client re­la­tion­ships

Last year
China
Manufacturing

In­sulin users face short­age with two of Eli Lil­ly's in­sulins through the be­gin­ning of April

Last year
Pharma
Manufacturing

Mar­ket­ingRx roundup: Phar­ma ad­ver­tis­ers and March Mad­ness; No­vo lands near top of Fast Com­pa­ny's in­no­va­tion list

Last year
Pharma
Marketing

Viking Ther­a­peu­tics plans Ph2 tri­al for oral obe­si­ty drug af­ter pos­i­tive ear­ly-stage da­ta

Last year
R&D

Phath­om’s first cam­paign for acid block­er Vo­quez­na is the lat­est to use tele­health to reach po­ten­tial pa­tients ...

Last year
Pharma
Marketing

Edge­wood's $20M Se­ries A; Nanoscope to pur­sue FDA ap­proval for eye gene ther­a­py lat­er this year

Last year
News Briefing

A new re­port ques­tions whether dig­i­tal di­a­betes pro­grams are worth the cost

Last year
Health Tech

Brazil aims to man­u­fac­ture its own cell ther­a­pies — at a frac­tion of the cur­rent cost

Last year
Cell/Gene Tx
Manufacturing

Prax­is touts topline da­ta for epilep­sy drug in first of four read­outs

Last year
R&D

Stoke un­veils new da­ta on ge­net­ic epilep­sy drug — and in­vestors are stoked

Last year
R&D

Ex­clu­sive: Athena Coun­tou­ri­o­tis' Aven­zo nabs $150M to in-li­cense more as­sets

Last year
Financing
Startups

Alex­ion adds fourth in­di­ca­tion for C5 in­hibitor Ul­tomiris in rare au­toim­mune dis­or­der

Last year
R&D
Pharma

NIH sends BioN­Tech 'no­tice of de­fault' over Covid vac­cine roy­al­ties

Last year
Pharma
Coronavirus

As­traZeneca ad­vances Fasen­ra's mar­ket­ing with new cam­paign that's on Tik­Tok for first time

Last year
Pharma
Marketing

ARPA-H calls on AI de­vel­op­ers to help tack­le cy­ber­at­tacks

Last year
AI
FDA+

The US could up­end bio­phar­ma man­u­fac­tur­ing. WuXi ri­vals have an open­ing

Last year
China
In Focus

Ax­some clears Phase 3 in nar­colep­sy; Nkar­ta eyes $240M raise

Last year
News Briefing

In­vivyd scores EUA for Covid-19 pre­ven­tion drug Pem­gar­da

Last year
R&D

In small ac­qui­si­tion, Ab­b­Vie adds Lan­dos and its IBD drug to post-Hu­mi­ra plans

Last year
Deals
R&D

Nu­va­tion inks all-stock deal for US-Chi­na on­col­o­gy biotech An­Heart

Last year
Startups
Deals
First page Previous page 180181182183184185186 Next page Last page
A service from the Financial Times